Skip to main content


Hepatology International


Hepatology International OnlineFirst articles

08.08.2022 | Review Article

Management of spontaneous portosystemic shunts at the time of liver transplantation: treatment or observation? Results of a systematic review

Spontaneous portosystemic shunts (SPSS) develop because of portal hypertension in cirrhotic patients to circumvent the increased vascular resistances of the intrahepatic portal system. SPSS incidence increases with hepatic failure gravity [ 1 ] …

04.08.2022 | Original Article

Diversity of the nucleic acid forms of circulating HBV in chronically infected patients and its impact on viral cycle

Hepatitis B virus (HBV) remains a major public health problem, affecting more than 250 million people chronically infected, worldwide. Chronic hepatitis related to HBV infection may progress toward development of liver cirrhosis and contribute to …

29.07.2022 | Review Article

Liver transplantation in patients with acute-on-chronic liver failure

Acute-on-chronic liver failure (ACLF) is a dynamic syndrome associated with a very high short-term mortality. Hence, the ongoing assessment of treatment response, an expedited liver transplant evaluation and listing, and the determination of …

Open Access 29.07.2022 | Letter to the Editor

Response to: Aspirin for patients after TIPS. An old dog with new tricks?

We would like to thank Dr. Wang, Dr. Qi and their team for their interest and appreciate the raised issues regarding our study entitled ‘Aspirin improves transplant-free survival after TIPS implantation in patients with refractory ascites—a …

25.07.2022 | Review Article

Pan-genotypic direct-acting antivirals for patients with hepatitis C virus infection and chronic kidney disease stage 4 or 5

Hepatitis C virus (HCV) infection is a major health problem with significant clinical and economic burdens in patients with chronic kidney disease (CKD) stage 4 or 5. Current guidelines recommend pan-genotypic direct-acting antivirals (DAAs) to be …

Über diese Zeitschrift

Hepatology International is a peer-reviewed journal featuring articles written by clinicians, clinical researchers and basic scientists is dedicated to research and patient care issues in hepatology. This journal focuses mainly on new and emerging diagnostic and treatment options, protocols and molecular and cellular basis of disease pathogenesis, new technologies, in liver and biliary sciences.

Hepatology International publishes original research articles related to clinical care and basic research; review articles; consensus guidelines for diagnosis and treatment; invited editorials, and controversies in contemporary issues. The journal does not publish case reports..

Hepatology International requests that all authors comply to Springer’s ethical policies. These ethical statements should be clearly indicated on all articles for all 3 ethics statements and for all authors mentioned by name. These statements should be placed at the end of each article just before the Reference section.

To visit our ethics statements please visit the following links:

Conflict of Interest and Ethical Standards:

Informed Consent:

Statement of Human and Animal Rights:

Hepatology International is the official journal of the Asian Pacific Association for the Study of the Liver (APASL).

Now indexed by ISI

Hepatology International
Volume 1/2007 - Volume 16/2022
Springer India
Elektronische ISSN
Print ISSN

Neu im Fachgebiet Innere Medizin


Bestellen Sie unseren kostenlosen Newsletter Update Innere Medizin und bleiben Sie gut informiert – ganz bequem per eMail.